Upload Image (Max 20MB per Image)
GlaxoSmithKline (GSK) has announced the FDA approval of four-strain seasonal influenza (flu) virus vaccine, Fluarix Quadrivalent, to immunize adults and children of three years age and more, in the US. The intramuscular vaccine is ...
Tags: FDA, Seasonal Flu Virus Vaccine, clinical technology